Summary:
Former Amicus Therapeutics CEO and incoming CEO of BIO, John Crowley shares lessons learned about centering patients and caregivers in medicine development, and some of his priorities that R&D leaders should be aware of.
Mr Crowley also discusses how pharma can get better at storytelling, and how the patient engagement movement has evolved (and what that means for industry).
